Compile Data Set for Download or QSAR
Report error Found 1106 for UniProtKB: P32238
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM21133(Tyr-D-Nle-Gly-Trp-NMeNle-Asp-Phe-NH2 | (3S)-3-[(2S...)
Affinity DataAssay Description:Log IC50 values for each test compound were determined from nonlinear regression analysis of data collected from two independent experiments performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2008
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM21135((3S)-3-[(2S)-2-[(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3...)
Affinity DataAssay Description:Log IC50 values for each test compound were determined from nonlinear regression analysis of data collected from two independent experiments performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2008
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM21136((3S)-3-[(2S)-2-[(2S)-2-(2-{2-[(2S)-2-amino-3-(4-hy...)
Affinity DataAssay Description:Log IC50 values for each test compound were determined from nonlinear regression analysis of data collected from two independent experiments performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2008
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM21145((3S)-3-[(2S)-2-[(2R)-2-{2-[(2R)-2-[(2S)-2-amino-3-...)
Affinity DataAssay Description:Log IC50 values for each test compound were determined from nonlinear regression analysis of data collected from two independent experiments performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2008
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM21147((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)
Affinity DataKd:  1.90nM EC50:  28nMAssay Description:Log IC50 values for each test compound were determined from nonlinear regression analysis of data collected from two independent experiments performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2008
Entry Details Article
PubMed
LigandPNGBDBM50421963(CHEMBL2310856)
Affinity DataEC50:  0.700nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50455609(CHEMBL2310857)
Affinity DataEC50:  6.90nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004483(CHEMBL269355 | CCK7 analogue)
Affinity DataEC50:  1.30nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004490(N-(1-Carbamoyl-2-phenyl-ethyl)-3-(2-{3-(1H-indol-3...)
Affinity DataEC50:  15nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004474(CHEMBL316949 | N-(1-Carbamoyl-2-phenyl-ethyl)-3-{2...)
Affinity DataEC50:  0.990nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004488(CHEMBL414793 | CCK7 analogue)
Affinity DataEC50:  50nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004475(CCK7 analogue | CHEMBL439591 | N-(1-Carbamoyl-2-ph...)
Affinity DataEC50:  3.70nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004480(CHEMBL316944 | CCK7 analogue)
Affinity DataEC50:  0.640nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004477(N-(1-Carbamoyl-2-phenyl-ethyl)-3-({2-[3-(1H-indol-...)
Affinity DataEC50:  0.100nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004481(CHEMBL99499 | CCK7 analogue)
Affinity DataEC50:  2.5nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004492(CHEMBL98720 | CCK7 analogue)
Affinity DataEC50:  71nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004482(CCK7 analogue | CHEMBL263742 | N-(1-Carbamoyl-2-ph...)
Affinity DataEC50:  0.320nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004489(CHEMBL318010 | CCK7 analogue)
Affinity DataEC50:  3.70nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50004485(CHEMBL98631 | CCK7 analogue)
Affinity DataEC50:  140nMAssay Description:Evaluated in vitro for maximal stimulatory activity for amylase release relative to CCK-8 in guinea pig tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50329178((S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl...)
Affinity DataEC50:  0.0130nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 0.01 nM (Rvb = 7 to 14 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50329178((S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl...)
Affinity DataEC50:  0.0100nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 0.1 nM (Rvb = 7 to 14 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50329178((S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl...)
Affinity DataEC50:  0.00200nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 0.316 nM (Rvb = 7 to 14...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50329178((S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl...)
Affinity DataEC50:  0.190nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 1 nM (Rvb = 7 to 14 pM)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50074832(CHEMBL156605)
Affinity DataEC50:  0.0190nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 10 nM (Rvb = 7 to 14 pM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50072419(2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-...)
Affinity DataEC50:  0.0200nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 10 nM (Rvb = 7 to 14 pM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50074832(CHEMBL156605)
Affinity DataEC50:  0.0140nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 100 nM (Rvb = 7 to 14 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50072419(2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-...)
Affinity DataEC50:  0.0510nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 100 nM (Rvb = 7 to 14 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50074832(CHEMBL156605)
Affinity DataEC50:  0.0390nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 1000 nM (Rvb = 7 to 14 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50072419(2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-...)
Affinity DataEC50:  0.120nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as CCK EC50 measured as intracellular calcium responses at 1000 nM (Rvb = 7 to 14 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50072419(2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-...)
Affinity DataEC50:  90nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as stimulation of intracellular calcium responsesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50074832(CHEMBL156605)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as stimulation of intracellular calcium responsesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50329178((S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl...)
Affinity DataEC50:  0.800nMAssay Description:Activity at CCK1R (unknown origin) expressed in CHO cells assessed as stimulation of intracellular calcium responsesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2016
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50202113((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(2S)-2-...)
Affinity DataEC50:  28nMAssay Description:Activity at human CCK1 receptor expressed in HEK293 cells assessed as level of [3H]inositol produced relative to controlMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50262613((4-(3-chlorophenyl)piperazin-1-yl)(1-(3-methoxyphe...)
Affinity DataEC50:  74nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263230(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(2...)
Affinity DataEC50:  0.0770nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263229(CHEMBL505225 | CHEMBL505969 | 3-(4-(1-(2,3-dihydro...)
Affinity DataEC50:  0.0930nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263228(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-...)
Affinity DataEC50:  0.140nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263227(3-(4-(2-(2,4-difluorophenyl)-1-(3-ethoxyphenyl)-1H...)
Affinity DataEC50:  0.0530nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50245187(CHEMBL504861 | CHEMBL446789 | 3-(4-(1-(3-ethoxyphe...)
Affinity DataEC50:  0.0560nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263226(CHEMBL506201 | CHEMBL498942 | 3-(4-(1-(3-ethoxyphe...)
Affinity DataEC50:  0.0480nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50245180(CHEMBL505409 | CHEMBL505727 | 3-(4-(1-(3-ethoxyphe...)
Affinity DataEC50:  0.0940nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263225((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(4-fluo...)
Affinity DataEC50:  0.260nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263186((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-tolyl...)
Affinity DataEC50:  0.120nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263185((1-(3-ethoxyphenyl)-2-(2-fluoro-4-methylphenyl)-1H...)
Affinity DataEC50:  0.130nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263184((1-(3-ethoxyphenyl)-2-(2-fluorophenyl)-1H-imidazol...)
Affinity DataEC50:  0.530nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263140((1-(3-ethoxyphenyl)-2-(4-fluorophenyl)-1H-imidazol...)
Affinity DataEC50:  0.25nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50245193(CHEMBL453083 | CHEMBL503822 | (1-(3-ethoxyphenyl)-...)
Affinity DataEC50:  0.730nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263139((1-(3-ethoxyphenyl)-2-(2-fluoro-4-methylphenyl)-1H...)
Affinity DataEC50:  1.90nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263104((2-(2,4-difluorophenyl)-1-(3-ethoxyphenyl)-1H-imid...)
Affinity DataEC50:  1.10nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
University of Arizona Tucson

LigandPNGBDBM50263103((2-(2,6-difluorophenyl)-1-(3-ethoxyphenyl)-1H-imid...)
Affinity DataEC50:  4.40nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 1106 total ) | Next | Last >>
Jump to: